Skip to main content
Scott Irwin, MD, Psychiatry, Los Angeles, CA

ScottAIrwinMDPhD

Psychiatry Los Angeles, CA

Psychosomatic Medicine

Director Patient and Family Support Program and Professor of Psychiatry and Behavioral Neurosciences; Cedars-Sinai Health System, Cedars-Sinai Cancer, and Department of Psychiatry and Behavioral Neurosciences

Dr. Irwin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Irwin's full profile

Already have an account?

  • Office

    Cedars-Sinai Health System
    8700 Beverly Blvd
    Los Angeles, CA 90048
    Phone+1 310-423-0638

Education & Training

  • University of California (San Diego) Medical Center
    University of California (San Diego) Medical CenterResidency, Psychiatry, 2002 - 2006
  • University of Illinois College of Medicine
    University of Illinois College of MedicineClass of 2002
  • University of Illinois at Urbana-Champaign
    University of Illinois at Urbana-ChampaignPhD, Neuroanatomy, 2000
  • University of California, Los Angeles
    University of California, Los AngelesBS, Psychobiology, 1994

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2003 - 2025
  • American Board of Psychiatry and Neurology Psychiatry
  • American Board of Psychiatry and Neurology Consultation-Liaison Psychiatry

Awards, Honors, & Recognition

  • Scholar Advanced Research Institute in Geriatric Mental Health, 2014
  • Visiting Professorship Program Award Academy of Psychosomatic Medicine, 2011
  • Honoree, Health Care Champion Awards for Innovation and Research San Diego Business Journal, 2010
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Caregiving at the end-of-life  
    Pottie, C.G., Montross-Thomas, L., Burch, K.A., and Irwin, S.A, Journal of Palliative Medicine, 1/1/2014
  • What did I miss? A qualitative assessment of the impact of patient suicide on hospice clinical staff  
    Fairman N, Montross LP, Whitmore S, Meier E, Irwin SA, Journal of Palliative Medicine, 1/1/2014
  • Association Between Hospice Care and Psychological Outcomes in Alzheimer’s Family Caregivers  
    Irwin, S.A., Mausbach, B.T., Koo, D., Fairman, N., Roepke, S.K., Chattillion, E.A., Dimsdale, J.E., Patterson, T.L., Ancoli-Israel, S., Mills, P.J., von Kanel, R., Zie..., Journal of Palliative Medicine, 1/1/2013
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Hospice Women’s Reflections on Wisdom: A Qualitative Case Series
    Marrone, L., Montross, L., Jeste, D., Irwin, S.A., Holzer, J., Moore, K., Rivas, T., and De Cervantes-Montheith, American Association of Geriatric Psychiatry, 1/1/2014
  • A Retrospective Chart Review of the Use of Ketamine to Treat Depression in Hospice Patients
    Morrison, K., Iglewicz, A., and Irwin, S.A, American Academy of Hospice and Palliative Medicine Annual Meeting, 3/1/2013
  • Ketamine for the Management of Depression in Palliative Care: An Update on the Science
    Irwin, S.A., Hirst, J., Fairman, N., and Prommer E, American Academy of Hospice and Palliative Medicine Annual Meeting, 3/1/2013
  • Join now to see all

Lectures

  • Geriatrics Career Panel 
    La Jolla, CA - 7/30/2014
  • Clinical Challenges with Depression Comorbidities and the Palliative Care Patient 
    Los Angeles, CA - 2/25/2014
  • The Opportunity for Healthcare via Palliative Care 
    San Diego, CA - 1/23/2014
  • Join now to see all

Press Mentions

  • ABVC BioPharma Provides ABV-1601 Update on Phase I Site Initiation Visit Conducted at Cedars-Sinai Medical Center (CSMC)
    ABVC BioPharma Provides ABV-1601 Update on Phase I Site Initiation Visit Conducted at Cedars-Sinai Medical Center (CSMC)April 10th, 2023
  • Cedars-Sinai Medical Center Joins Phase I Clinical Study of ABVC BioPharma’s Medication for Treating Depression in Cancer Patients
    Cedars-Sinai Medical Center Joins Phase I Clinical Study of ABVC BioPharma’s Medication for Treating Depression in Cancer PatientsNovember 2nd, 2022
  • Cedars-Sinai Medical Center Joins Phase I Clinical Study of ABVC BioPharma’s Medication for Treating Depression in Cancer Patients
    Cedars-Sinai Medical Center Joins Phase I Clinical Study of ABVC BioPharma’s Medication for Treating Depression in Cancer PatientsNovember 2nd, 2022
  • Join now to see all

Grant Support

  • Improving Psychiatric Interventions At The END Of LifeNational Institute Of Mental Health2010–2011
  • Expression And Function Of FMRP During DevelopmentNational Institute Of Mental Health1996–2002